NIH-funded research NIH-funded research

How brain cells move and translate messages to stay healthy in Alzheimer’s and related dementias

Official title: Effect of FTD/ALS mutations in RNA binding proteins on mRNA transport and local translation

Funded at University of South Carolina at Columbia · NIH-11594227 · Data updated 2026-11-12

A study to understand how RNA binding proteins affect the way brain cells transport and translate messages, which may influence Alzheimer’s and related dementias.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of South Carolina at Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startAugust 15, 2026
Project endJuly 31, 2029
Funding year2026
Award (this year)$249,000
NIH project number4R00AG088305-02
Project IDNIH-11594227 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with FTD/ALS-related mutations or dementia with similar RNA-binding protein disruptions who could participate in related follow-up studies.

Less likely to help

People without these specific mutations or without a potential follow-on study may not directly benefit.

What this research studies

Researchers will use patient-derived neurons with FTD/ALS mutations to map how RNA messages are moved inside neurons and where they are translated. They will apply advanced techniques to see if messages travel in single granules or in multiple components, and how local protein production is directed to mitochondria and other destinations. The goal is to uncover the basic cellular steps that go wrong in dementia-related diseases and how these processes could become targets for therapies. This work may help identify new points where treatment could support neuron health and communication.

Why it matters

Potential benefit: If successful, this research could identify new cellular targets to protect neurons and slow progression in Alzheimer’s disease and related dementias.

How similar studies have gone: Other studies using iPSC-derived neurons and ribosome profiling have shown it’s possible to map RNA transport and local translation in neurons, but direct links to FTD/ALS mutations remain under investigation.

Where this research is happening

  • University of South Carolina at Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Ryan, Veronica Hanley — University of South Carolina at Columbia
  • Study coordinator: Ryan, Veronica Hanley

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.